Eugenol is one of the best-established aroma constituents in the AromaForge archive and the defining phenylpropanoid of clove-type oils. The live evidence base is stronger than for many other constituents: public sources support identity, repeated natural occurrence, modern fragrance-safety assessment, and a sizeable mechanistic literature centered on ion-channel modulation, antimicrobial effects, and inflammation-related signaling in preclinical systems. That said, much of the bioactivity literature remains cell, ex vivo, or animal based, so AromaForge should position eugenol as a major chemistry and safety-relevant constituent with substantial preclinical evidence, not as a stand-alone medical treatment.
Chemical identity and composition
PubChem and NIST identify eugenol as C10H12O2 with InChIKey RRAFCDWBNXTKKO-UHFFFAOYSA-N. The 2022 RIFM update classifies it as a Cramer Class I fragrance material and notes broad natural occurrence in clove, cinnamon, basil, allspice, laurel, tarragon, lemon balm, and wormwood-type matrices. In the archive it is the chemistry-defining major constituent of clove bud, clove leaf, cinnamon leaf, and several basil or allspice records.
Aroma and practical use
- Use the recorded clove-like, warm spicy, phenolic, dry, sharp descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
The 2022 RIFM update concluded that eugenol was not genotoxic, reported a repeated-dose NOAEL of 300 mg/kg/day, and assigned a skin-sensitization NESIL of 5900 microg/cm2 under the assessed fragrance-use conditions.
This is the strongest public safety synthesis located in this pass and also reports that current inhalation and reproductive endpoints were below the applied TTC framework.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
A 2006 Journal of Dental Research study reported that eugenol inhibited action potentials and voltage-gated sodium currents in rat dental afferent neurons, with the abstract stating the effect remained after TRPV1 antagonism.
This is one of the clearest constituent-level mechanistic explanations for the long-standing dental use context of eugenol, but it is still preclinical neurophysiology rather than a clinical efficacy study.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2021 Biochemical and Biophysical Research Communications paper found that eugenol dose-dependently inhibited capsaicin-activated mouse TRPV1 currents while showing different effects on proton-activated currents and no modulation of heat-activated TRPV1 in the tested system.
The abstract supports a more nuanced ion-channel story than a simple agonist label and helps explain why eugenol literature can report both activation-like and inhibitory sensory effects depending on assay conditions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe 2022 RIFM update treats eugenol as a skin sensitizer with a quantitative risk-assessment framework rather than as an unrestricted benign fragrance material.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
RIFM reported that eugenol was not phototoxic and not expected to be photoallergenic based on UV/Vis spectra and older in vivo data.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Public bioactivity literature for eugenol is much broader than for many aroma constituents, but most findings are still preclinical and should not be converted into treatment claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
ThymolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Thymol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →citralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citral report →MentholAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Menthol report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →alpha-PineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Pinene report →Dodecanoic acidAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Dodecanoic acid report →nootkatoneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read nootkatone report →NeralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Neral report →geranialAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read geranial report →(E)-cinnamaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read (E)-cinnamaldehyde report →IsoeugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Isoeugenol report →trans-AnetholeOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read trans-Anethole report →MethyleugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Methyleugenol report →(E)-CaryophylleneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
cell study · effect
No source citation attached.
Read (E)-Caryophyllene report →alpha-HumuleneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read alpha-Humulene report →GeraniolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Geraniol report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read Limonene report →Eugenyl acetateAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
review · whole_oil
No source citation attached.
Read Eugenyl acetate report →delta-CadineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vivo nonhuman · whole_oil
No source citation attached.
Read delta-Cadinene report →benzyl alcoholAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · effect
No source citation attached.
Read benzyl alcohol report →NeralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · effect
No source citation attached.
Read Neral report →How the effects were investigated
voltage-gated sodium channel inhibition
Patch-clamp work in rat dental primary afferent neurons found that eugenol inhibited both tetrodotoxin-sensitive and tetrodotoxin-resistant sodium currents and did so independently of TRPV1 blockade.
This experimental finding does not establish benefit, dose or safety in people using this blend.
mode-selective TRPV1 modulation
A 2021 electrophysiology study found that eugenol inhibited capsaicin-activated TRPV1 currents, altered proton-activated responses in a concentration-dependent way, and did not modulate heat-activated TRPV1 under the tested conditions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- This pass did not attempt to normalize the very large eugenol literature into disease-by-disease summaries because much of it remains preclinical and would risk overstating human relevance.
- No single open primary source was added here for a standalone human efficacy trial on isolated eugenol outside the broader dental-use literature.
- Archive oil files often cite a simple 0.5% dermal shorthand for eugenol-rich oils, but the constituent record here relies on the fuller RIFM fragrance-safety framework rather than restating a single universal topical limit.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.